BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 16585872)

  • 41. Perceptual analyses of spasmodic dysphonia before and after treatment.
    Cannito MP; Woodson GE; Murry T; Bender B
    Arch Otolaryngol Head Neck Surg; 2004 Dec; 130(12):1393-9. PubMed ID: 15611398
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Voice disorders in female teachers assessed by Voice Handicap Index].
    Niebudek-Bogusz E; Kuzańska A; Woźnicka E; Sliwińska-Kowalska M
    Med Pr; 2007; 58(5):393-402. PubMed ID: 18274090
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Endoscopic mucosal suturing of vocal fold with placement of stent for the treatment of glottic stenoses.
    Xu W; Han D; Hu H; Chen X; Li H; Hou L; Zhang L
    Head Neck; 2009 Jun; 31(6):732-7. PubMed ID: 19260136
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Applicability of Voice Handicap Index to the evaluation of voice therapy effectiveness in teachers].
    Niebudek-Bogusz E; Kuzańska A; Błoch P; Domańska M; Woźnicka E; Politański P; Sliwińska-Kowalska M
    Med Pr; 2007; 58(6):501-9. PubMed ID: 18421932
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Voice abnormalities and their relation with motor dysfunction in Parkinson's disease.
    Midi I; Dogan M; Koseoglu M; Can G; Sehitoglu MA; Gunal DI
    Acta Neurol Scand; 2008 Jan; 117(1):26-34. PubMed ID: 18031561
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Botulinum toxin injection for treatment of spasmodic dysphonia: experience at Srinagarind Hospital.
    Srirompotong S; Saeseow P; Taweesaengsuksakul R; Kharmwan S; Srirompotong S
    J Med Assoc Thai; 2006 Dec; 89(12):2077-80. PubMed ID: 17214059
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Selective laryngeal adductor denervation-reinnervation: a new surgical treatment for adductor spasmodic dysphonia.
    Berke GS; Blackwell KE; Gerratt BR; Verneil A; Jackson KS; Sercarz JA
    Ann Otol Rhinol Laryngol; 1999 Mar; 108(3):227-31. PubMed ID: 10086613
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Optimising outcome assessment of voice interventions, II: Sensitivity to change of self-reported and observer-rated measures.
    Steen IN; MacKenzie K; Carding PN; Webb A; Deary IJ; Wilson JA
    J Laryngol Otol; 2008 Jan; 122(1):46-51. PubMed ID: 17498325
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adductor spastic dysphonia: three years after recurrent laryngeal nerve resection.
    Aronson AE; De Santo LW
    Laryngoscope; 1983 Jan; 93(1):1-8. PubMed ID: 6823165
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Subjective and objective assessment of voice quality after surgical treatment of overgrowth changes in vocal folds].
    Ratajczak J; Wojdas A; Rapiejko P; Jurkiewicz D
    Pol Merkur Lekarski; 2005 Sep; 19(111):327-30. PubMed ID: 16358858
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Voice-related Quality of Life in laryngectomees: assessment using the VHI and V-RQOL symptom scales.
    Kazi R; De Cordova J; Singh A; Venkitaraman R; Nutting CM; Clarke P; Rhys-Evans P; Harrington KJ
    J Voice; 2007 Nov; 21(6):728-34. PubMed ID: 16815670
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Listening: the key to diagnosing spasmodic dysphonia.
    Braden MN; Hapner ER
    ORL Head Neck Nurs; 2008; 26(1):8-12. PubMed ID: 18274236
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of antituberculosis treatment on self assessment, perceptual analysis and acoustic analysis of voice quality in laryngeal tuberculosis patients.
    Yelken K; Guven M; Topak M; Gultekin E; Turan F
    J Laryngol Otol; 2008 Apr; 122(4):378-82. PubMed ID: 17592656
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Selective lateral laser thyroarytenoid myotomy for adductor spasmodic dysphonia.
    Hussain A; Shakeel M
    J Laryngol Otol; 2010 Aug; 124(8):886-91. PubMed ID: 20426891
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Voice handicap index in Swedish.
    Ohlsson AC; Dotevall H
    Logoped Phoniatr Vocol; 2009; 34(2):60-6. PubMed ID: 19308791
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Considerations for initial dosing of botulinum toxin in treatment of adductor spasmodic dysphonia.
    Rosow DE; Parikh P; Vivero RJ; Casiano RR; Lundy DS
    Otolaryngol Head Neck Surg; 2013 Jun; 148(6):1003-6. PubMed ID: 23535709
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Voice prostheses: long-term follow-up retrospective study (three- to sixteen-year follow-up of 22 patients).
    Trussart C; Lawson G; Remacle M
    Rev Laryngol Otol Rhinol (Bord); 2003; 124(5):299-304. PubMed ID: 15144025
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Psychological aspects of adductor spasmodic dysphonia: a prospective population controlled questionnaire study.
    Kaptein AA; Hughes BM; Scharloo M; Hondebrink N; Langeveld TP
    Clin Otolaryngol; 2010 Feb; 35(1):31-8. PubMed ID: 20447160
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Retrospective study of 116 patients with non-organic voice disorders: efficacy of mental imagery and laryngeal shaking.
    Voerman MS; Langeveld AP; van Rossum MA
    J Laryngol Otol; 2009 May; 123(5):528-34. PubMed ID: 18761769
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acoustic measures of symptoms in abductor spasmodic dysphonia.
    Edgar JD; Sapienza CM; Bidus K; Ludlow CL
    J Voice; 2001 Sep; 15(3):362-72. PubMed ID: 11575633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.